Management Team

Stefan Aigner

Stefan Aigner, M.D., CFA

Chairman, Chief Executive Officer

  • More than 30 years of broad healthcare industry experience
  • Co-founder and CEO of Inspirion Delivery Technologies and Inspirion Delivery Sciences. Garnered approval of two abuse-deterrent products and raised funding that exceeded $50 MM while negotiating a significant non-dilutive partnership with Daiichi Sankyo.
  • Former EVP of corporate development at Alpharma (acquired by King Pharmaceuticals in 2008 for $1.6 billion).
  • Co-Founder and EVP of business development and scientific affairs at Reliant Pharmaceuticals. Built a fully integrated pharmaceutical company with 1,400 employees (acquired by GlaxoSmithKline in 2007 for $1.7 billion).
  • Healthcare management consultant for the Wilkerson Group
  • Board of publicly traded Cipher Pharmaceuticals.
Hafid Touam

Hafid Touam

Chief Business Officer

  • More than 30 years of pharmaceutical industry experience in drug delivery systems and product development technology.
  • Spent 20 years with Ethypharm S.A. of France of which 12 years as CEO of Ethypharm North America.
  • Headed company strategy, established and managed alliances and partnerships with both specialty pharma and generic companies in the US, Canada, and Latin America, primarily in pain management and treatment of substance abuse disorders.
  • Spent 10 years in Europe with Glatt AG & Glatt GmbH, world leaders in pharmaceutical products processing.
Keith James

Keith James

Chief Financial Officer

  • Seasoned operational finance professional with 25 years of experience in pharma, medical devices, and technology.
  • Has supported IPO processes, equity capital raises, and secured debt facility and revolver.
  • Provided key cross-functional support across the human resources, information technology, and commercial operations functions to create successful processes in both startup and large global companies to support a number of commercial launches.
Eric Kinzler

Eric Kinzler, PhD

VP Medical & Regulatory Affairs; VP Quality Assurance

  • More than 20 years in specialty pharma, taking products from development through approval and launch: regulatory strategy, medical affairs, compliance, and commercial readiness.
  • Leads medical, regulatory, and quality functions at Protega, including labeling, promotional review, and safety oversight for RoxyBond.
  • Previously head of medical affairs at Inspirion Delivery Sciences and Xanodyne Pharmaceuticals, responsible for labeling, publications, promotional review, pharmacovigilance, medical information, and grants.
  • Advises sponsors of abuse-deterrent and other novel therapies on FDA meetings, advisory committee preparation, and launch.
  • Board of MDDUS at Supernus Pharmaceuticals.
David Calandrillo

David Calandrillo

VP Sales

  • More than 18 years of progressive pharmaceutical industry experience spanning sales, sales training, sales leadership, marketing, and wholesale distribution.
  • Proven track record of driving revenue growth, building and leading high-performing teams, and successfully launching and scaling products in competitive markets.
  • Combines deep field expertise and strategic marketing insights to align commercial objectives across the various stakeholders.
  • Recognized for developing talent, strengthening market access, and delivering results through disciplined execution, cross-functional collaboration, and customer-focused leadership.
Sarah Flora

Sarah Flora

Director of Sales

  • More than 15 years of healthcare experience with startups, driving sales growth and improving patient access; most recently led national access and sales strategy for an AI-driven diagnostics platform, overseeing U.S. sales.
  • Director of Operations at Cingulate Pharmaceuticals; built and executed the market access strategy for the launch of an ADHD therapy using proprietary time-release technology.
  • Vice President of Business Development at Nueterra Capital; led the launch of a specialized total joint ambulatory surgery center and developed reimbursement arrangements for total joint procedures in Texas and the Mid-Atlantic region.
  • Began her healthcare career syndicating operational and real estate funds for physician investors, raising over $12 million for medical office buildings, skilled nursing, and memory care facilities.
Sharon Salwan

Sharon Salwan

Senior Director, Operations Generalist

  • More than two decades of experience within a pharmaceutical environment. 
  • Lead the implementation of marketing tactics with multi-million-dollar budgets. 
  • Comprehensive experience leading marketing and communication efforts for commercial operations across multiple functional areas.